Cardinal Strategic Wealth Guidance’s CVS Health CVS Stock Holding History

Cardinal Strategic Wealth Guidance’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,730	Closed	-$216K	–	61
2023 Q4	$216K	Sell	2,730 -810	-23%	-$57.6K	0.09%	60
2023 Q3	$247K	Buy	3,540 +310	+10%	+$22K	0.11%	55
2023 Q2	$223K	Sell	3,230 -400	-11%	-$28.5K	0.1%	60
2023 Q1	$270K	Sell	3,630 -5	-0.1%	-$419	0.13%	52
2022 Q4	$339K	Hold	3,635	–	–	0.16%	53
2022 Q3	$348K	Hold	3,635	–	–	0.18%	47
2022 Q2	$338K	Hold	3,635	–	–	0.17%	49
2022 Q1	$370K	Hold	3,635	–	–	0.17%	52
2021 Q4	$376K	Hold	3,635	–	–	0.18%	55
2021 Q3	$308K	Hold	3,635	–	–	0.16%	57
2021 Q2	$303K	Hold	3,635	–	–	0.16%	57
2021 Q1	$274K	Hold	3,635	–	–	0.16%	58
2020 Q4	$248K	Hold	3,635	–	–	0.15%	52
2020 Q3	$211K	Hold	3,635	–	–	0.15%	49
2020 Q2	$236K	Hold	3,635	–	–	0.18%	49
2020 Q1	$216K	Sell	3,635 -400	-10%	-$26.7K	0.2%	46
2019 Q4	$299K	Buy	+4,035	New	+$283K	0.26%	49

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cardinal Strategic Wealth Guidance's CVS Position: Q1 2024 in Review

Cardinal Strategic Wealth Guidance sold out of CVS Health (CVS) in Q1 2024, closing a stake of 2,730 shares — an estimated $216K sold.

Cardinal Strategic Wealth Guidance first reported a position in CVS in Q4 2019 and held it in 17 quarters. The position peaked at $376K in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Cardinal Strategic Wealth Guidance reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
Cardinal Strategic Wealth Guidance sold 2,730 CVS Health shares in Q1 2024, an estimated $216K.
Cardinal Strategic Wealth Guidance first reported a position in CVS Health in Q4 2019 and held it in 17 quarters.
Cardinal Strategic Wealth Guidance's CVS Health position peaked at $376K in Q4 2021.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Cardinal Strategic Wealth Guidance's 13F filing for Q1 2024, filed 25 Apr 2024.